Stay updated on Savolitinib Combo in EGFRm+ NSCLC Clinical Trial
Sign up to get notified when there's something new on the Savolitinib Combo in EGFRm+ NSCLC Clinical Trial page.

Latest updates to the Savolitinib Combo in EGFRm+ NSCLC Clinical Trial page
- ChecktodayNo Change Detected
- Check8 days agoChange DetectedThe study record now includes data-sharing information (IPD Sharing URL, plan, access criteria) and added study documents (SAP, CSP, CSR, PDFs) along with sponsor-related resources and keywords. A prior error placeholder was replaced by actual content.SummaryDifference67%

- Check15 days agoChange DetectedThe page shows a new revision tag: v3.6.5, replacing the previous v3.6.4. This appears to be a software update to the page rather than a change to the trial information.SummaryDifference0.0%

- Check22 days agoChange DetectedMilestone dates in the study timeline were updated: new dates (2026-07-30, 2027-03-15, 2026-07) were added and older dates (2026-02-27, 2026-03-30, 2026-02-06, 2026-02) were removed. These updates reflect revised scheduling for study milestones and potential reporting timelines.SummaryDifference0.2%

- Check30 days agoChange DetectedThe page displays Revision: v3.6.4, updating the site’s release version from v3.6.3.SummaryDifference0.0%

- Check51 days agoChange DetectedThe page revision was updated from v3.6.2 to v3.6.3, indicating a minor update to the page version.SummaryDifference0.0%

- Check58 days agoChange DetectedThe page now displays Revision: v3.6.2, replacing the prior Revision: v3.6.0, indicating an update to the page’s revision history.SummaryDifference0.0%

Stay in the know with updates to Savolitinib Combo in EGFRm+ NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Savolitinib Combo in EGFRm+ NSCLC Clinical Trial page.